329966-95-2Relevant academic research and scientific papers
Derivatives of 1-amino-1-(hetero)arylaminocarbonyl-6-hydroxyaminocarbonylhexane useful in the treatment of tumors
-
, (2015/11/11)
The present invention provides the compound having the formula: wherein each of R1 and R2 is, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyr
Aminosuberoyl hydroxamic acids (ASHAs): A potent new class of HDAC inhibitors
Belvedere, Sandro,Witter, David J.,Yan, Jiaming,Secrist, J. Paul,Richon, Victoria,Miller, Thomas A.
, p. 3969 - 3971 (2008/02/09)
Histone deacetylase (HDAC) inhibitors that target Class I and Class II HDACs are currently in advanced clinical trials for the treatment of cancer. Vorinostat (Zolinza, SAHA) is a hydroxamic acid approved for the treatment of patients with cutaneous T-cel
